1-5 of 5
Karl Gaal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Venetoclax and Hypomethylating Agents (HMA) in Adult Patients with KMT2A-Rearranged Leukemias

Brian Ball, Shukaib Arslan, Paul Koller, Joyce Murata-Collins, Michelle Afkhami, Raju Pillai, Karl Gaal, Amandeep Salhotra, Monzr M. Al Malki, Ahmed Aribi, Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Ryotaro Nakamura, Eileen P. Smith, Forrest Stewart, Guido Marcucci, Vinod A. Pullarkat, Ibrahim Aldoss
Journal: Blood
Blood (2021) 138 (Supplement 1): 3430.
https://doi.org/10.1182/blood-2021-148670
Published: 2021
Journal Articles

Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor–treated CML stem cells

Bin Zhang, Su Chu, Puneet Agarwal, Victoria L. Campbell, Lisa Hopcroft, Heather G. Jørgensen, Allen Lin, Karl Gaal, Tessa L. Holyoake, Ravi Bhatia
Journal: Blood
Blood (2016) 128 (23): 2671–2682.
https://doi.org/10.1182/blood-2015-11-679928
Published: 2016
Journal Articles

Immunologic and Clinical Responses To a CD20-Targeted Immunocytokine, DI-Leu16-IL2, In Relapsed Non-Hodgkin Lymphoma

Ryotaro Nakamura, Robert Chen, MD, Joycelynne Palmer, PhD, Karl Gaal, MD, Auayporn Nademanee, MD, Leslie Popplewell, MD, James E. Talmadge, PhD, Stephen Gillies, PhD, David Colcher, PhD, Stephen J. Forman, MD, Andrew Raubitschek, MD
Journal: Blood
Blood (2013) 122 (21): 1808.
https://doi.org/10.1182/blood.V122.21.1808.1808
Published: 2013
Journal Articles

Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study

Clinical Trials & Observations
Jan W. Gratama, Michael Boeckh, Ryotaro Nakamura, Jan J. Cornelissen, Rik A. Brooimans, John A. Zaia, Stephen J. Forman, Karl Gaal, Kurtis R. Bray, Gail H. Gasior, Christopher S. Boyce, Linda A. Sullivan, Paula C. Southwick
Journal: Blood
Blood (2010) 116 (10): 1655–1662.
https://doi.org/10.1182/blood-2010-03-273508
Published: 2010
Journal Articles

Improved Outcomes Using Tacrolimus/Sirolimus for graft Versus Host Disease prophylaxis with a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant for Myelofibrosis

David S. Snyder, MD, Joycelynne Palmer, Karl Gaal, Anthony Selwyn Stein, Vinod Pullarkat, Nyana Vora, Ryotaro Nakamura, Firoozeh Sahebi, Stephen J Forman
Journal: Blood
Blood (2008) 112 (11): 4410.
https://doi.org/10.1182/blood.V112.11.4410.4410
Published: 2008